Search All News
A new analysis of almost 10,000 patients found that tumors could be stratified into 112 subtypes regardless of the cancer’s origin.
An ancient antivirus system in our cells silences foreign DNA—but also hinders gene therapy. New research shows how the system could be disabled.
Pathology’s new recruit, Kevin Gardner, talks about health disparities and the need for more diversity among research participants.
With the use of personalized clinical trials, Karina Davidson hopes to upend the way new drugs are tested and revolutionize the practice of medicine.
- May 1, 2017
Columbia University researchers have created a new topology-based tool that generates a roadmap of the ways in which a stem cell becomes differentiated.
- July 8, 2016
$4 million grant gives Columbia, Weill Cornell Medicine, NewYork-Presbyterian, and NYC Health + Hospitals key role in precision medicine cohort program.
- July 31, 2015
Tom Maniatis discusses the potential of precision medicine and how success will depend on Columbia’s commitment to building and enhancing multiple disciplines related to the field.
- June 3, 2015
The latest gift from dedicated philanthropists Florence and Herbert Irving will benefit precision medicine, cancer, and faculty development.
- April 3, 2015
A new prenatal DNA test detects more cases of Down syndrome than standard screening, a study by Columbia and UCSF researchers has found.
- March 16, 2015
At Columbia, every pediatric cancer patient’s tumor is sequenced, so personalized treatment may be considered.
- January 30, 2015
Two Columbia University Medical Center faculty members were present today when President Obama provided details of the precision medicine initiative he announced during this year’s State of the Union address.
- December 10, 2014
The founding director of Columbia’s Institute for Genomic Medicine explains how precision medicine is essential to practicing good medicine.